Conference speaker

Cristina Mayor-Ruiz obtained her PhD in 2017 at the CNIO (Madrid), where she unraveled novel mechanisms of resistance to anticancer therapies in the group of Dr. Fernández-Capetillo. In 2018, she joined the lab of G. Winter (CeMM, Vienna) for her postdoc and innovated chemical biology approaches in the field of targeted protein degradation. Since January 2021, she is a Group Leader at the Institute for Research in Biomedicine (IRB) in Barcelona.Her research focuses on developing proximity-inducing drugs with therapeutic interest, and on tackling biological questions that involve (dys)regulation of the cellular proteolytic machinery. Dr. Mayor-Ruiz has been honored with national and international awards, such as an ERC Starting grant.